THE MINISTER OF STATE FOR CHEMICALS AND FERTILIZERS(SHRI SRIKANT KUMAR JENA)
(a) Different Pharmaceuticals companies mainiy under Indian Pharmaceutical Alliance are involved
in drug discovery and formulation research alongwith Government Departments/Institutions like
Department of Science and Technology, Department of Biotechnology, ICMR, AYUSH etc. The Government
of India is running different schemes for drug discovery through different Departments along with
newly formed Department of Pharmaceuticals. Drug discovery and development is a continuous and
long drawn process involving 10-12 years of time aiming at manufacturing safe, potent and
affordable drugs.
The Indian pharmaceutical Industry has`geared up for research for development of new drugs. There
are about 58 companies in Pharmaceuticals sector having R&D centres approved by DSIR u/s 35 (2AB)
of the Income Tax Act. Out of these about 15 companies are carrying out research & development in
new drugs and have built up impressive R&D infrastructure and expertise in chemical research,
pharmaceutical research, fermentation research as well as new drug discovery research (NDDR) and
research in novel drug delivery systems. The therapeutic areas in which these companies have
developed lead molecules are malaria, urology, metabolic disorders, cardiovascular indications,
cancer, diabetes, dyslipidemia, obesity, inflammation & pain, staphylococcal infections,
respiratory infections, skin infections, anti-migraine, anti-TB and anti-psoriasis.
(b) Different Ministries have different plan outlay. The newly created Deptt. of
Pharmaceuticals has aliocated fund for research mainly to National
Institute of Pharmaceutical Education & Research (NIPER). The budget
outlay for each of the fast three years and the current year on R&D by
Department of Science & Technology (DST) and NIPER are at annexures
I & II. The amount of NIPER includes the amount provided by the DST
also.
(c)to (f): This Department is coordinating with other Departments like
DST/Department of Biotechnology (DBT) etc. which are engaged in R&D
activities to finalise the various tasks to be undertaken by the Department
to obviate duplicity. Presently Rs. 20 crores have been provided to
Department for the new schemes. The Department has formulated
various small R&D schemes which have been forwarded to the Planning
Commission for `in principle` approval.
The following incentives are available to industries for research & development in
drugs and Pharmaceuticals:
i) Weighted tax deduction of 150% on R&D expenditure approved under section 35(2AB) of the Income
tax Act.
ii) The R&D centres recognized by DSIR are also registered with DSIR for the purpose of availing
customs duty and excise exemption as per notification No. 24/2007- Customs dated 1st March 2007
and 16/2007-/Central Excise dated 1s March 2007.
(b) Details on the year-wise expenditure incurred/allocation of funds under Drugs
and Pharmaceuticals Research Programme of DST is given below:-
Year Loans(Rupees Grants-in Total in Crores) -aid (Rupees in Crores) (Rupees in Crores)
2006-07 35.00 25.00 60.00
2007-08 60.00 58.00 118.00
2008-09 56.50 40.00 96.50
2009-10 (BE) 66.00 30.00 96.00
Natioanl Institute of Parmaceutical Education & Research (NIPER) S.A.S. Nagar
Financial details for the 3 years (in crores)
(A) Continuing/ongoing schemes from 10th Plan
S.No. Particulars 2007-08 2008-09 2009-10
1 Diabities complications 0.95 2.00 0.80
2 Leads moleculars for TB, 1.10 1.50 0.80 Malaria and leishmania
3 Chiral Drugs/bio-chemo 0.36 0.35 0.30 enzymatic-transfermation
4 Nanotechnology & Drug 0.40 1.45 1.10 Delivery System
5 Impurity Profiling facility 0.17 0.19 0.21
Total (A) 2.98 5.49 3.27
(B) Infrastructure Development & New Schemes
1 Drug for most neglected diseases 0.31 2.20 4.06
Total (B) 0.31 2.20 4.06
GRAND TOTAL(A+B) 3.29 7.69 7.33